Welcome to CDC Stacks | Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012 - 37972 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012
  • Published Date:
    Aug 12 2015
  • Source:
    J Pediatric Infect Dis Soc. 5(4):395-402.


Public Access Version Available on: December 01, 2017 information icon
Please check back on the date listed above.
Details:
  • Pubmed ID:
    26407276
  • Pubmed Central ID:
    PMC4752432
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    Background

    Although the 1-dose varicella vaccination program, introduced in 1996, has led to significant declines in varicella disease, outbreaks continued to occur which led to the adoption of a 2-dose vaccination program in 2007. We previously reported an 88% decline in varicella-related hospitalizations and 59% decline in outpatient visits during 1994–2002. We now update data on varicella health care utilization with 10 years of additional data, during a period of stabilizing first-dose coverage and rapidly-increasing second dose coverage.

    Methods

    We performed a retrospective cohort study using claims data from 1994–2012 Truven Health MarketScan® databases. We examined trends in rates of varicella-related outpatient visits and hospitalizations for MarketScan enrollees aged 0–49 years, including outpatient laboratory testing, outpatient antiviral use and pediatric strokes, with 1994–1995 as the pre-vaccination period and 2006–2012 as the 2-dose varicella vaccination period.

    Results

    Varicella outpatient visits declined 84% in 2012 versus the pre-vaccination period, with a 60% decline during the 2-dose period. Varicella hospitalizations declined 93% in 2012 versus the pre-vaccination period, with a 38% decline during the 2-dose period. The proportion of those with a varicella outpatient visit having varicella laboratory testing increased from 6% in 2003 to 17% in 2012. There were 21,445 (17%) with a claim for antivirals, which was relatively stable over time. There was no reduction in pediatric strokes during 1994–2012.

    Conclusion

    We document from our large study population that the varicella vaccination program has led to significant declines in outpatient visits and hospitalizations from the pre-vaccination period through 2012, with additional declines during the 2-dose varicella vaccination period.

  • Supporting Files:
    No Additional Files